Rain Oncology Inc. (NASDAQ:RAIN – Get Rating) insider Boxer Capital, Llc sold 995,000 shares of Rain Oncology stock in a transaction dated Monday, May 22nd. The shares were sold at an average price of $1.25, for a total transaction of $1,243,750.00. Following the sale, the insider now directly owns 1,152,212 shares in the company, valued […]
Rain Oncology (NASDAQ:RAIN – Get Rating) was downgraded by SVB Leerink from an “outperform” rating to a “market perform” rating in a note issued to investors on Monday, PriceTargets.com reports. Other analysts also recently issued reports about the stock. Mizuho lowered their price target on shares of Rain Oncology from $18.00 to $17.00 and set […]
Rain Oncology (NASDAQ:RAIN – Get Rating) was downgraded by equities research analysts at Lifesci Capital from an “outperform” rating to a “market perform” rating in a research note issued to investors on Monday, PriceTargets.com reports. RAIN has been the subject of several other research reports. Guggenheim cut Rain Oncology from a “buy” rating to a […]
Rain Oncology (NASDAQ:RAIN – Get Rating) was downgraded by analysts at Oppenheimer from an “outperform” rating to a “market perform” rating in a research report issued on Monday, The Fly reports. A number of other equities analysts have also commented on RAIN. SVB Securities assumed coverage on shares of Rain Oncology in a research note […]
Rain Oncology Inc. (NASDAQ:RAIN – Get Rating) has received an average rating of “Buy” from the ten ratings firms that are currently covering the company, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy rating. The average 12 month target price among brokers that have updated their coverage on the stock in […]